Normal metabolic fexibility despite insulin resistance women with polycystic ovary syndrome

Endocrine Journal

Volumn 60, Issue 9, 2013, Pages 1107-1113

  Adamska, Agnieszka ^a   Karczewska Kupczewska, Monika ^a,b   Nikołajuk, Agnieszka ^b   Otziomek, Elzbieta ^a   Górska, Maria ^a   Kowalska, Irina ^a   Straczkowski, Marek ^a,b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b INSTITUTE OF ANIMAL REPRODUCTION AND FOOD RESEARCH   (Poland)

Author keywords

Metabolic flexibility; Pcos; Substrate oxidation

Indexed keywords

CARBOHYDRATE; GLUCOSE; INSULIN; LIPID; ANTIDIABETIC AGENT; CARBON DIOXIDE;

ADULT; ARTICLE; BODY MASS; CALORIMETRY; CARBOHYDRATE METABOLISM; CARBOHYDRATE OXIDATION; COMORBIDITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIPID OXIDATION; LUNG GAS EXCHANGE; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; BLOOD; DRUG EFFECT; LIPID METABOLISM; METABOLISM; OXYGEN CONSUMPTION; YOUNG ADULT; COMPLICATION; DRUG EFFECTS;

ADIPOSITY; ADULT; BODY MASS INDEX; CALORIMETRY, INDIRECT; CARBOHYDRATE METABOLISM; CARBON DIOXIDE; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; OBESITY; OVERWEIGHT; OXYGEN CONSUMPTION; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 84884924484     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ13-0115     Document Type: Article

References (26)

1. Dunaif A (1997) Insulin resistance and the polycys-tic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18: 774-800.
2. Moran C, Tena G, Moran S, et al. (2010) Prevalence of polycystic ovary syndrome and related disorders in mexican women. Gynecol Obstet Invest 69: 274-280.
3. Diamanti-Kandarakis E, Dunaif A (2012) Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 33: 981-1030.
4. Kowalska I, Straczkowski M, Nikolajuk A, et al. (2007) Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum Reprod 22: 1824-1829.
5. Nikolajuk A, Kowalska I, Karczewska-Kupczewska M, et al. (2010) Serum soluble glycoprotein 130 concentration is inversely related to insulin sensitivity in women with polycystic ovary syndrome. Diabetes 59: 1026-1029.
6. DeUgarte CM, Bartolucci AA, Azziz R (2005) Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 83: 1454-1460.
7. Stepto NK, Cassar S, Joham AE, et al. (2013) Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod 28: 777-784.
8. Rodin DA, Bano G, Bland JM, et al. (1998) Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women. Clin Endocrinol (Oxf) 49: 91-99.
9. Kelley DE, Mandarino LJ (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexami-nation. Diabetes 49: 677-683.
10. Adamska A, Nikołajuk A, Karczewska-Kupczewska M, et al. (2012) Relationships between serum adiponec-tin and soluble TNF-α receptors and glucose and lipid oxidation in lean and obese subjects. Acta Diabetol 49: 17-24.
11. Kelley D, Goodpaster B, Wing R, Simoneau J (1999) Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277: E1130-1141.
12. Ukropcova B, Sereda O, de Jonge L, et al. (2007) Family history of diabetes links impaired substrate switching and reduced mitochondrial content in skeletal muscle. Diabetes 56: 720-727.
13. Damsbo P, Vaag A, Hother-Nielsen O, Beck-Nielsen H (1991) Reduced glycogen synthase activity in skel-etal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34: 239-245.
14. Skov V, Glintborg D, Knudsen S, et al. (2007) Reduced expression of nuclear-encoded genes involved in mito-chondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome. Diabetes 56: 2349-2355.
15. Svendsen PF, Nilas L, Nørgaard K, et al. (2008) Obesity, body composition and metabolic disturbances in poly-cystic ovary syndrome. Hum Reprod 23: 2113-2121.
16. Glintborg D, Højlund K, Andersen NR, et al. (2008) Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment. J Clin Endocrinol Metab 93: 3618-3626.
17. Kowalska I, Adamska A, Malecki MT, et al. (2012) Impact of the FTO gene variation on fat oxidation and its potential infuence on body weight in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 77: 120-125.
18. Højlund K, Glintborg D, Andersen NR, et al. (2008) Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment. Diabetes 57: 357-366.
19. Eriksen M, Pørneki AD, Skov V, et al. (2010) Insulin resistance is not conserved in myotubes established from women with PCOS. PLoS One 5: e14469.
20. Group REA-SPCW (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81: 19-25.
21. DeFronzo R, Tobin J, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-223.
22. Karczewska-Kupczewska M, Straczkowski M, Adamska A, et al. (2010) Insulin sensitivity, metabolic fexibility, and serum adiponectin concentration in women with anorexia nervosa. Metabolism 59: 473-477.
23. Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84: 3666-3672.
24. Book CB, Dunaif A (1999) Selective insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab 84: 3110-3116.
25. Dunaif A, Xia J, Book CB, et al. (1995) Excessive insulin receptor serine phosphorylation in cultured fbro-blasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 96: 801-810.
26. Morin-Papunen LC, Vauhkonen I, Koivunen RM, et al. (2000) Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome. Hum Reprod 15: 1266-1274.